SonoMotion, a US-based medical device startup, raised $10m in Series B funding.
The round was co-led by Advanced MedTech Holdings (AMTH), Southeast Asia’s largest medical device business, and existing investors MedVenture Partners, Inc and BioVentures Investors.
The funds will be used to support the clinical development and commercialisation of SonoMotion’s key ultrasound-based solutions – Break Wave(TM) and Stone Clear(TM).
Led by Dr Oren Levy, Chief Executive Officer, SonoMotion is medical device startup that is developing non-invasive solutions for the treatment of kidney stones. It is advancing:
– Break Wave(TM), an ultrasound solution that fragments kidney stones non-invasively and
– Stone Clear(TM), a non-invasive ultrasound-based tool to reposition kidney stones within the kidney and ureter, in 2020.
FinSMEs
12/11/2019